Integrated management of safety and efficacy for drugs and bioequivalence testing eyed

The Korea Food and Drug Administration has recently announced that a series of measures, such as streamlined affairs covering management of safety and efficacy for drugs and bioequivalence testing, have been finally adopted to reform its drug-related administration organizations.

The restructuring plan of the KFDA structure, which will take place in coming February 4, came after the revised ...